Pfizer buys stake in French gene company in deal worth up to $636M
March 21, 2019 at 09:51 AM EDT
French gene company Vivet is developing a treatment for the rare and possibly fatal Wilson disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|